| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 685014 | Null | 0.0283958753782624 | 0.068595813 |
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0283958753782624 | 0.2960238 |
| NSC 734562 | 6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride | 0.0283958753782624 | 0.19973168 |
| NSC 756166 | GSK312948A | 0.0283958753782624 | 0.043403447 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0283958753782624 | 0.089726479 |
| NSC 705871 | 1H-Indole, 5-bromo-3-[2-(2-pyridinyl)-4-thiazolyl]- | 0.0284045326811616 | 0.13921656 |
| NSC 715664 | Phenol, 4-(5,6-dimethyl-1H-benzimidazol-2-yl)- 2,6-bis(1,1-dimethylethyl)- | 0.0284045326811616 | 0.13657692 |
| NSC 726718 | 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid | 0.0284045326811616 | 0.23674865 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.0284045326811616 | 0.0092072279 |
| NSC 731155 | 6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt | 0.0284045326811616 | 0.17456983 |